CN Stock MarketDetailed Quotes

600332 Guangzhou Baiyunshan Pharmaceutical Holdings

Watchlist
  • 29.02
  • -0.55-1.86%
Market Closed Dec 13 15:00 CST
47.18BMarket Cap13.78P/E (TTM)

Guangzhou Baiyunshan Pharmaceutical Holdings Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
-13.52%17.19B
-22.31%16.23B
-2.43%19.75B
-5.29%21.31B
-8.30%19.87B
-7.37%20.89B
-14.12%20.25B
0.55%22.5B
-9.52%21.67B
2.07%22.55B
Transactional financial assets
-75.38%14M
-92.97%4M
-92.97%4M
-92.97%4M
12.24%56.87M
12.24%56.87M
468.73%56.87M
--56.87M
1,166.71%50.67M
153.34%50.67M
Notes receivable and accounts receivable
0.28%17.34B
1.36%17.41B
1.69%17.49B
-0.01%15.98B
5.81%17.3B
9.03%17.18B
13.66%17.2B
13.86%15.98B
14.93%16.35B
6.96%15.75B
-Notes receivable
-14.58%661.65M
-35.72%689.74M
-37.87%777.48M
-22.75%870.88M
-34.67%774.56M
-15.05%1.07B
-1.13%1.25B
-7.75%1.13B
28.51%1.19B
-3.89%1.26B
-Accounts receivable
0.97%16.68B
3.83%16.72B
4.79%16.72B
1.72%15.11B
8.97%16.52B
11.13%16.1B
15.01%15.95B
15.93%14.86B
13.99%15.16B
8.02%14.49B
Other receivables (including interest and dividends)
-9.93%971.41M
18.31%1.06B
-5.44%1.12B
-4.23%878.49M
3.19%1.08B
-18.08%895.1M
-4.76%1.18B
-22.18%917.24M
1.81%1.05B
4.93%1.09B
-Dividend receivable
-98.57%1.5M
-96.70%1.5M
-72.00%61.26M
-72.00%61.26M
-51.93%105.16M
-86.79%45.4M
-36.36%218.77M
-36.36%218.77M
45.84%218.77M
129.18%343.77M
-Other receivable
----
24.46%1.06B
----
----
----
13.46%849.7M
----
-16.34%698.48M
----
-15.98%748.91M
Advance payment
-24.42%648.23M
25.01%708.49M
95.23%982.77M
-2.12%818.36M
38.32%857.65M
-8.57%566.75M
-18.08%503.4M
7.29%836.05M
-10.83%620.05M
-1.61%619.87M
Inventories
17.46%11.34B
17.34%10.75B
10.10%9.85B
7.83%11.51B
14.43%9.66B
11.85%9.16B
2.45%8.95B
2.24%10.67B
-1.59%8.44B
0.37%8.19B
Receivable financing
32.20%3.69B
22.97%3.93B
9.02%5.08B
13.56%3.61B
6.86%2.79B
21.81%3.2B
33.68%4.66B
0.34%3.18B
-1.34%2.61B
-4.53%2.62B
Non-current assets due within one year
207.52%272.58M
-57.64%254.95M
-48.94%283.96M
-75.60%159.36M
-86.31%88.64M
451.75%601.9M
--556.08M
--653.12M
--647.53M
--109.09M
Other current assets
28.96%1.58B
24.88%1.6B
-33.04%1.4B
-24.42%1.71B
-13.98%1.22B
-14.66%1.28B
275.88%2.09B
173.39%2.26B
173.06%1.42B
194.65%1.5B
Total current assets
0.24%53.05B
-3.49%51.94B
0.94%55.96B
-1.89%55.98B
0.13%52.92B
2.54%53.82B
3.92%55.44B
8.05%57.06B
2.35%52.86B
5.13%52.49B
Non Current assets
Debt investment
46.62%9.57B
112.40%9.53B
69.37%6.45B
106.55%6.54B
122.56%6.53B
452.74%4.48B
346.58%3.81B
401.73%3.16B
369.29%2.93B
31.09%811.31M
Other equity investment
-0.67%104.4M
-1.35%104.19M
-5.46%104.48M
-5.26%103.81M
-9.69%105.1M
-15.83%105.62M
-12.34%110.51M
-11.22%109.57M
-27.82%116.38M
-22.29%125.48M
Other non-current financial assets
89.74%1.02B
-0.56%1.01B
-3.67%1.01B
-3.17%1.01B
-53.93%539.35M
0.32%1.01B
80.12%1.05B
80.89%1.04B
360.69%1.17B
307.63%1.01B
Investment real estate
11.36%147.66M
10.12%146.78M
-26.58%150.06M
-17.87%169.77M
-36.39%132.6M
-36.36%133.3M
-3.72%204.39M
-3.40%206.71M
-13.58%208.45M
-2.78%209.47M
Long-term equity investment
7.51%1.93B
-1.41%1.8B
23.62%1.83B
13.99%1.81B
8.38%1.79B
12.22%1.83B
-7.48%1.48B
1.36%1.58B
-11.54%1.65B
-11.26%1.63B
Fixed assets
----
13.92%4.42B
----
----
----
11.34%3.88B
----
10.80%3.71B
----
19.47%3.49B
Constru in process
----
25.06%2.69B
----
----
----
27.78%2.15B
----
34.80%2.11B
----
13.20%1.68B
Productive biological assets
-15.93%1.84M
-15.32%1.93M
-14.76%2.02M
-14.23%2.11M
-13.74%2.19M
-13.29%2.28M
-12.86%2.37M
-12.46%2.46M
-12.08%2.54M
-11.73%2.63M
Intangible assets
8.41%2.84B
8.61%2.86B
11.60%2.87B
11.66%2.89B
2.86%2.62B
2.74%2.63B
0.03%2.57B
0.10%2.59B
5.13%2.55B
5.50%2.56B
Development expenditure
38.53%366.38M
37.39%351.78M
31.98%333.02M
28.76%309.89M
1,811.46%264.48M
1,570.14%256.04M
1,832.90%252.33M
2,177.44%240.67M
54.00%13.84M
102.62%15.33M
Goodwill
0.17%830.85M
0.17%830.85M
0.00%829.47M
0.00%829.47M
0.00%829.47M
0.00%829.47M
0.00%829.47M
0.00%829.47M
0.47%829.47M
0.47%829.47M
Long deferred expense
-3.26%188.72M
3.69%184.89M
10.43%185.74M
13.84%189.88M
38.36%195.08M
27.11%178.31M
24.49%168.2M
25.91%166.8M
27.00%141M
24.71%140.28M
Deferred tax assets
24.33%1.17B
10.55%1.22B
33.50%1.19B
34.46%1.16B
15.69%940.69M
32.75%1.1B
12.38%892.5M
8.95%865.34M
5.82%813.13M
8.70%830.88M
Usufruct assets
-21.03%637.56M
-7.66%676.54M
-9.20%706.32M
-2.83%728.9M
16.50%807.35M
-3.88%732.66M
2.57%777.86M
-2.56%750.16M
-17.26%693.02M
-11.62%762.26M
Other non current assets
-54.22%206.17M
-54.05%210.45M
-6.77%212.67M
-63.96%86.45M
104.35%450.33M
112.09%458.04M
4.64%228.13M
42.35%239.83M
14.15%220.37M
18.24%215.97M
Total non current assets
22.29%26.21B
31.55%26.03B
24.82%22.74B
28.42%22.6B
28.36%21.43B
38.26%19.79B
33.02%18.22B
32.27%17.6B
28.99%16.69B
12.96%14.31B
Total assets
6.59%79.26B
5.93%77.97B
6.85%78.7B
5.25%78.59B
6.90%74.35B
10.19%73.61B
9.87%73.66B
12.93%74.67B
7.69%69.55B
6.71%66.8B
Liabilities
Current liabilities
Short term loan
15.36%9.41B
8.14%9.24B
9.98%9.48B
-8.66%7.8B
-3.20%8.16B
-3.96%8.55B
-10.85%8.62B
1.31%8.54B
-7.07%8.43B
-13.34%8.9B
Notes payable and accounts payable
1.23%16.35B
1.84%15.29B
4.11%15.14B
4.85%15.69B
6.56%16.15B
12.10%15.01B
6.97%14.54B
1.55%14.96B
9.23%15.15B
4.32%13.39B
-Notes payable
3.54%3.65B
8.92%3.34B
11.58%3.85B
2.22%3.84B
2.66%3.53B
19.67%3.06B
5.78%3.45B
9.13%3.76B
27.16%3.44B
2.53%2.56B
-Accounts payable
0.58%12.69B
0.03%11.95B
1.78%11.29B
5.73%11.84B
7.70%12.62B
10.31%11.95B
7.35%11.09B
-0.77%11.2B
4.89%11.72B
4.75%10.83B
Contract liabilities
0.59%1.21B
3.52%1.45B
3.61%1.85B
-3.80%5.43B
4.24%1.2B
18.00%1.4B
17.28%1.78B
105.97%5.64B
-28.49%1.15B
-11.00%1.19B
Advance receipts
--5.25M
--5.96M
----
----
----
----
----
----
----
----
Salaries payable
-7.91%1.05B
-3.56%1.04B
-2.77%959.68M
5.91%1.07B
16.77%1.14B
13.71%1.08B
13.21%987M
6.25%1.01B
4.34%976.89M
10.11%947.45M
Taxs payable
-22.87%373.52M
4.99%443.41M
31.41%713.11M
2.89%386.55M
1.23%484.26M
-21.51%422.35M
2.60%542.67M
60.91%375.71M
11.90%478.37M
44.97%538.12M
Other payable (including interest and dividends)
32.01%6.28B
10.18%5.78B
5.31%5.49B
1.75%4.92B
7.58%4.76B
11.09%5.25B
14.12%5.22B
5.63%4.83B
-9.05%4.42B
17.88%4.72B
-Dividend payable
1,550.82%698.69M
-1.20%213.88M
0.65%54.76M
13.76%62.21M
-22.21%42.32M
5.40%216.47M
0.48%54.41M
-1.99%54.68M
-2.62%54.41M
18.01%205.38M
-Other payable
----
10.67%5.57B
----
----
----
11.35%5.03B
----
5.73%4.78B
----
17.88%4.52B
Non current liabilities due within one year
306.16%1.44B
-3.93%849.64M
-63.00%253.06M
-64.65%249.83M
-44.34%354.2M
249.45%884.43M
170.77%684.04M
187.52%706.73M
148.81%636.4M
8.64%253.09M
Other current liabilities
-67.47%144.21M
-66.60%153.79M
-55.11%228.24M
-47.50%695.88M
-39.86%443.24M
-37.79%460.48M
184.56%508.4M
282.99%1.33B
302.13%737.06M
397.26%740.22M
Total current liabilities
10.93%36.26B
3.64%34.25B
3.74%34.12B
-3.10%36.24B
2.19%32.69B
7.73%33.05B
5.44%32.89B
15.94%37.4B
2.46%31.99B
2.06%30.68B
Current liabilities
Long term loan
-15.57%2.65B
11.72%3.26B
11.90%3.51B
102.76%3.32B
78.84%3.13B
132.97%2.91B
316.63%3.14B
117.74%1.64B
128.16%1.75B
62.87%1.25B
Long term account payable
----
-3.46%19.67M
----
----
----
-0.12%20.37M
----
-0.33%20.4M
----
-0.33%20.4M
Long term salaries pay
-1.73%291.83K
-1.01%295.35K
-5.93%293.37K
-7.84%293.26K
-7.83%296.96K
-2.06%298.36K
3.33%311.86K
4.59%318.22K
3.94%322.2K
-1.61%304.66K
Estimate liabilities
4.62%59.35M
30.27%59.39M
26.49%55.7M
17.05%55.93M
27.37%56.73M
1.88%45.59M
-18.28%44.04M
-11.47%47.78M
-37.55%44.54M
-37.43%44.75M
Deferred tax liabilities
39.55%647.36M
1.20%655.99M
60.30%645.87M
62.08%639.53M
31.32%463.9M
84.69%648.18M
16.96%402.9M
18.95%394.59M
14.52%353.26M
16.35%350.95M
Long term deferred income
7.92%1B
10.47%1.02B
10.13%1.03B
7.57%1B
-5.74%929.99M
-2.32%923.89M
1.47%930.76M
12.59%930.93M
19.21%986.57M
12.92%945.81M
Lease liabilities
-18.83%512.3M
-6.85%538.16M
-3.48%559.51M
5.93%578.19M
32.47%631.14M
16.25%577.75M
17.14%579.67M
9.67%545.84M
-5.84%476.45M
-5.29%497M
Other non current liabilities
1.80%54.14M
1.73%54.18M
1.06%54.3M
2.69%54.7M
0.06%53.18M
-1.37%53.26M
-0.91%53.74M
-0.31%53.27M
-2.95%53.15M
-0.08%54M
Total non current liabilities
-6.56%4.94B
8.11%5.6B
13.58%5.87B
56.20%5.67B
43.46%5.29B
63.82%5.18B
95.90%5.17B
43.16%3.63B
44.06%3.69B
22.60%3.16B
Total liabilities
8.49%41.2B
4.24%39.85B
5.08%39.99B
2.15%41.91B
6.46%37.98B
12.97%38.23B
12.50%38.06B
17.93%41.03B
5.61%35.67B
3.68%33.84B
Shareholders equity
Paid-in capital
0.00%1.63B
0.00%1.63B
0.00%1.63B
0.00%1.63B
0.00%1.63B
0.00%1.63B
0.00%1.63B
0.00%1.63B
0.00%1.63B
0.00%1.63B
Capital reserve funds
0.08%10.11B
0.08%10.11B
0.00%10.11B
0.00%10.11B
1.49%10.11B
1.49%10.11B
1.49%10.11B
1.49%10.11B
0.73%9.96B
0.73%9.96B
Surplus reserve funds
8.04%2.25B
8.04%2.25B
8.04%2.25B
8.08%2.25B
9.20%2.08B
9.20%2.08B
9.20%2.08B
9.20%2.08B
10.95%1.91B
10.95%1.91B
Retained profit
6.65%22.25B
12.11%22.29B
13.62%22.92B
14.77%20.96B
16.26%20.86B
16.54%19.88B
15.96%20.17B
17.15%18.26B
16.77%17.95B
17.19%17.06B
Other composite income
-1.45%-19.4M
-45.70%-19.37M
-21.97%-22.91M
-88.70%-24.34M
-129.24%-19.13M
-9.75%-13.29M
-0.97%-18.78M
26.18%-12.9M
56.52%-8.34M
44.23%-12.11M
Shareholders equity without minority interests
4.51%36.22B
7.65%36.26B
8.57%36.88B
8.90%34.92B
10.28%34.66B
10.30%33.69B
10.05%33.97B
10.33%32.07B
9.97%31.43B
9.98%30.54B
Minority interests
6.69%1.83B
9.67%1.85B
12.37%1.84B
11.81%1.76B
-29.97%1.72B
-30.15%1.69B
-30.38%1.63B
-30.55%1.57B
9.95%2.45B
10.40%2.42B
Total shareholder equity
4.61%38.05B
7.75%38.12B
8.74%38.71B
9.04%36.68B
7.37%36.38B
7.33%35.38B
7.19%35.6B
7.38%33.64B
9.96%33.88B
10.01%32.96B
Total liabilityies and equity
6.59%79.26B
5.93%77.97B
6.85%78.7B
5.25%78.59B
6.90%74.35B
10.19%73.61B
9.87%73.66B
12.93%74.67B
7.69%69.55B
6.71%66.8B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Daxin Certified Public Accountants (Special General Partnership)
--
--
--
Daxin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds -13.52%17.19B-22.31%16.23B-2.43%19.75B-5.29%21.31B-8.30%19.87B-7.37%20.89B-14.12%20.25B0.55%22.5B-9.52%21.67B2.07%22.55B
Transactional financial assets -75.38%14M-92.97%4M-92.97%4M-92.97%4M12.24%56.87M12.24%56.87M468.73%56.87M--56.87M1,166.71%50.67M153.34%50.67M
Notes receivable and accounts receivable 0.28%17.34B1.36%17.41B1.69%17.49B-0.01%15.98B5.81%17.3B9.03%17.18B13.66%17.2B13.86%15.98B14.93%16.35B6.96%15.75B
-Notes receivable -14.58%661.65M-35.72%689.74M-37.87%777.48M-22.75%870.88M-34.67%774.56M-15.05%1.07B-1.13%1.25B-7.75%1.13B28.51%1.19B-3.89%1.26B
-Accounts receivable 0.97%16.68B3.83%16.72B4.79%16.72B1.72%15.11B8.97%16.52B11.13%16.1B15.01%15.95B15.93%14.86B13.99%15.16B8.02%14.49B
Other receivables (including interest and dividends) -9.93%971.41M18.31%1.06B-5.44%1.12B-4.23%878.49M3.19%1.08B-18.08%895.1M-4.76%1.18B-22.18%917.24M1.81%1.05B4.93%1.09B
-Dividend receivable -98.57%1.5M-96.70%1.5M-72.00%61.26M-72.00%61.26M-51.93%105.16M-86.79%45.4M-36.36%218.77M-36.36%218.77M45.84%218.77M129.18%343.77M
-Other receivable ----24.46%1.06B------------13.46%849.7M-----16.34%698.48M-----15.98%748.91M
Advance payment -24.42%648.23M25.01%708.49M95.23%982.77M-2.12%818.36M38.32%857.65M-8.57%566.75M-18.08%503.4M7.29%836.05M-10.83%620.05M-1.61%619.87M
Inventories 17.46%11.34B17.34%10.75B10.10%9.85B7.83%11.51B14.43%9.66B11.85%9.16B2.45%8.95B2.24%10.67B-1.59%8.44B0.37%8.19B
Receivable financing 32.20%3.69B22.97%3.93B9.02%5.08B13.56%3.61B6.86%2.79B21.81%3.2B33.68%4.66B0.34%3.18B-1.34%2.61B-4.53%2.62B
Non-current assets due within one year 207.52%272.58M-57.64%254.95M-48.94%283.96M-75.60%159.36M-86.31%88.64M451.75%601.9M--556.08M--653.12M--647.53M--109.09M
Other current assets 28.96%1.58B24.88%1.6B-33.04%1.4B-24.42%1.71B-13.98%1.22B-14.66%1.28B275.88%2.09B173.39%2.26B173.06%1.42B194.65%1.5B
Total current assets 0.24%53.05B-3.49%51.94B0.94%55.96B-1.89%55.98B0.13%52.92B2.54%53.82B3.92%55.44B8.05%57.06B2.35%52.86B5.13%52.49B
Non Current assets
Debt investment 46.62%9.57B112.40%9.53B69.37%6.45B106.55%6.54B122.56%6.53B452.74%4.48B346.58%3.81B401.73%3.16B369.29%2.93B31.09%811.31M
Other equity investment -0.67%104.4M-1.35%104.19M-5.46%104.48M-5.26%103.81M-9.69%105.1M-15.83%105.62M-12.34%110.51M-11.22%109.57M-27.82%116.38M-22.29%125.48M
Other non-current financial assets 89.74%1.02B-0.56%1.01B-3.67%1.01B-3.17%1.01B-53.93%539.35M0.32%1.01B80.12%1.05B80.89%1.04B360.69%1.17B307.63%1.01B
Investment real estate 11.36%147.66M10.12%146.78M-26.58%150.06M-17.87%169.77M-36.39%132.6M-36.36%133.3M-3.72%204.39M-3.40%206.71M-13.58%208.45M-2.78%209.47M
Long-term equity investment 7.51%1.93B-1.41%1.8B23.62%1.83B13.99%1.81B8.38%1.79B12.22%1.83B-7.48%1.48B1.36%1.58B-11.54%1.65B-11.26%1.63B
Fixed assets ----13.92%4.42B------------11.34%3.88B----10.80%3.71B----19.47%3.49B
Constru in process ----25.06%2.69B------------27.78%2.15B----34.80%2.11B----13.20%1.68B
Productive biological assets -15.93%1.84M-15.32%1.93M-14.76%2.02M-14.23%2.11M-13.74%2.19M-13.29%2.28M-12.86%2.37M-12.46%2.46M-12.08%2.54M-11.73%2.63M
Intangible assets 8.41%2.84B8.61%2.86B11.60%2.87B11.66%2.89B2.86%2.62B2.74%2.63B0.03%2.57B0.10%2.59B5.13%2.55B5.50%2.56B
Development expenditure 38.53%366.38M37.39%351.78M31.98%333.02M28.76%309.89M1,811.46%264.48M1,570.14%256.04M1,832.90%252.33M2,177.44%240.67M54.00%13.84M102.62%15.33M
Goodwill 0.17%830.85M0.17%830.85M0.00%829.47M0.00%829.47M0.00%829.47M0.00%829.47M0.00%829.47M0.00%829.47M0.47%829.47M0.47%829.47M
Long deferred expense -3.26%188.72M3.69%184.89M10.43%185.74M13.84%189.88M38.36%195.08M27.11%178.31M24.49%168.2M25.91%166.8M27.00%141M24.71%140.28M
Deferred tax assets 24.33%1.17B10.55%1.22B33.50%1.19B34.46%1.16B15.69%940.69M32.75%1.1B12.38%892.5M8.95%865.34M5.82%813.13M8.70%830.88M
Usufruct assets -21.03%637.56M-7.66%676.54M-9.20%706.32M-2.83%728.9M16.50%807.35M-3.88%732.66M2.57%777.86M-2.56%750.16M-17.26%693.02M-11.62%762.26M
Other non current assets -54.22%206.17M-54.05%210.45M-6.77%212.67M-63.96%86.45M104.35%450.33M112.09%458.04M4.64%228.13M42.35%239.83M14.15%220.37M18.24%215.97M
Total non current assets 22.29%26.21B31.55%26.03B24.82%22.74B28.42%22.6B28.36%21.43B38.26%19.79B33.02%18.22B32.27%17.6B28.99%16.69B12.96%14.31B
Total assets 6.59%79.26B5.93%77.97B6.85%78.7B5.25%78.59B6.90%74.35B10.19%73.61B9.87%73.66B12.93%74.67B7.69%69.55B6.71%66.8B
Liabilities
Current liabilities
Short term loan 15.36%9.41B8.14%9.24B9.98%9.48B-8.66%7.8B-3.20%8.16B-3.96%8.55B-10.85%8.62B1.31%8.54B-7.07%8.43B-13.34%8.9B
Notes payable and accounts payable 1.23%16.35B1.84%15.29B4.11%15.14B4.85%15.69B6.56%16.15B12.10%15.01B6.97%14.54B1.55%14.96B9.23%15.15B4.32%13.39B
-Notes payable 3.54%3.65B8.92%3.34B11.58%3.85B2.22%3.84B2.66%3.53B19.67%3.06B5.78%3.45B9.13%3.76B27.16%3.44B2.53%2.56B
-Accounts payable 0.58%12.69B0.03%11.95B1.78%11.29B5.73%11.84B7.70%12.62B10.31%11.95B7.35%11.09B-0.77%11.2B4.89%11.72B4.75%10.83B
Contract liabilities 0.59%1.21B3.52%1.45B3.61%1.85B-3.80%5.43B4.24%1.2B18.00%1.4B17.28%1.78B105.97%5.64B-28.49%1.15B-11.00%1.19B
Advance receipts --5.25M--5.96M--------------------------------
Salaries payable -7.91%1.05B-3.56%1.04B-2.77%959.68M5.91%1.07B16.77%1.14B13.71%1.08B13.21%987M6.25%1.01B4.34%976.89M10.11%947.45M
Taxs payable -22.87%373.52M4.99%443.41M31.41%713.11M2.89%386.55M1.23%484.26M-21.51%422.35M2.60%542.67M60.91%375.71M11.90%478.37M44.97%538.12M
Other payable (including interest and dividends) 32.01%6.28B10.18%5.78B5.31%5.49B1.75%4.92B7.58%4.76B11.09%5.25B14.12%5.22B5.63%4.83B-9.05%4.42B17.88%4.72B
-Dividend payable 1,550.82%698.69M-1.20%213.88M0.65%54.76M13.76%62.21M-22.21%42.32M5.40%216.47M0.48%54.41M-1.99%54.68M-2.62%54.41M18.01%205.38M
-Other payable ----10.67%5.57B------------11.35%5.03B----5.73%4.78B----17.88%4.52B
Non current liabilities due within one year 306.16%1.44B-3.93%849.64M-63.00%253.06M-64.65%249.83M-44.34%354.2M249.45%884.43M170.77%684.04M187.52%706.73M148.81%636.4M8.64%253.09M
Other current liabilities -67.47%144.21M-66.60%153.79M-55.11%228.24M-47.50%695.88M-39.86%443.24M-37.79%460.48M184.56%508.4M282.99%1.33B302.13%737.06M397.26%740.22M
Total current liabilities 10.93%36.26B3.64%34.25B3.74%34.12B-3.10%36.24B2.19%32.69B7.73%33.05B5.44%32.89B15.94%37.4B2.46%31.99B2.06%30.68B
Current liabilities
Long term loan -15.57%2.65B11.72%3.26B11.90%3.51B102.76%3.32B78.84%3.13B132.97%2.91B316.63%3.14B117.74%1.64B128.16%1.75B62.87%1.25B
Long term account payable -----3.46%19.67M-------------0.12%20.37M-----0.33%20.4M-----0.33%20.4M
Long term salaries pay -1.73%291.83K-1.01%295.35K-5.93%293.37K-7.84%293.26K-7.83%296.96K-2.06%298.36K3.33%311.86K4.59%318.22K3.94%322.2K-1.61%304.66K
Estimate liabilities 4.62%59.35M30.27%59.39M26.49%55.7M17.05%55.93M27.37%56.73M1.88%45.59M-18.28%44.04M-11.47%47.78M-37.55%44.54M-37.43%44.75M
Deferred tax liabilities 39.55%647.36M1.20%655.99M60.30%645.87M62.08%639.53M31.32%463.9M84.69%648.18M16.96%402.9M18.95%394.59M14.52%353.26M16.35%350.95M
Long term deferred income 7.92%1B10.47%1.02B10.13%1.03B7.57%1B-5.74%929.99M-2.32%923.89M1.47%930.76M12.59%930.93M19.21%986.57M12.92%945.81M
Lease liabilities -18.83%512.3M-6.85%538.16M-3.48%559.51M5.93%578.19M32.47%631.14M16.25%577.75M17.14%579.67M9.67%545.84M-5.84%476.45M-5.29%497M
Other non current liabilities 1.80%54.14M1.73%54.18M1.06%54.3M2.69%54.7M0.06%53.18M-1.37%53.26M-0.91%53.74M-0.31%53.27M-2.95%53.15M-0.08%54M
Total non current liabilities -6.56%4.94B8.11%5.6B13.58%5.87B56.20%5.67B43.46%5.29B63.82%5.18B95.90%5.17B43.16%3.63B44.06%3.69B22.60%3.16B
Total liabilities 8.49%41.2B4.24%39.85B5.08%39.99B2.15%41.91B6.46%37.98B12.97%38.23B12.50%38.06B17.93%41.03B5.61%35.67B3.68%33.84B
Shareholders equity
Paid-in capital 0.00%1.63B0.00%1.63B0.00%1.63B0.00%1.63B0.00%1.63B0.00%1.63B0.00%1.63B0.00%1.63B0.00%1.63B0.00%1.63B
Capital reserve funds 0.08%10.11B0.08%10.11B0.00%10.11B0.00%10.11B1.49%10.11B1.49%10.11B1.49%10.11B1.49%10.11B0.73%9.96B0.73%9.96B
Surplus reserve funds 8.04%2.25B8.04%2.25B8.04%2.25B8.08%2.25B9.20%2.08B9.20%2.08B9.20%2.08B9.20%2.08B10.95%1.91B10.95%1.91B
Retained profit 6.65%22.25B12.11%22.29B13.62%22.92B14.77%20.96B16.26%20.86B16.54%19.88B15.96%20.17B17.15%18.26B16.77%17.95B17.19%17.06B
Other composite income -1.45%-19.4M-45.70%-19.37M-21.97%-22.91M-88.70%-24.34M-129.24%-19.13M-9.75%-13.29M-0.97%-18.78M26.18%-12.9M56.52%-8.34M44.23%-12.11M
Shareholders equity without minority interests 4.51%36.22B7.65%36.26B8.57%36.88B8.90%34.92B10.28%34.66B10.30%33.69B10.05%33.97B10.33%32.07B9.97%31.43B9.98%30.54B
Minority interests 6.69%1.83B9.67%1.85B12.37%1.84B11.81%1.76B-29.97%1.72B-30.15%1.69B-30.38%1.63B-30.55%1.57B9.95%2.45B10.40%2.42B
Total shareholder equity 4.61%38.05B7.75%38.12B8.74%38.71B9.04%36.68B7.37%36.38B7.33%35.38B7.19%35.6B7.38%33.64B9.96%33.88B10.01%32.96B
Total liabilityies and equity 6.59%79.26B5.93%77.97B6.85%78.7B5.25%78.59B6.90%74.35B10.19%73.61B9.87%73.66B12.93%74.67B7.69%69.55B6.71%66.8B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Daxin Certified Public Accountants (Special General Partnership)------Daxin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Ali Concept
Ali Concept
Intraday-1.54%
Spin-off Listing Expectations
Spin-off Listing Expectations
Intraday-1.69%
Superfungus
Superfungus
Intraday-1.74%